Lundbeck names former Novo Nordisk CEO Lars Fruergaard Jorgensen as next board chair
Lundbeck names former Novo Nordisk CEO Lars Fruergaard Jorgensen as next board chair Oct 18 (Reuters) - Danish drugmaker H. Lundbeck HLUNa.CO said on Sunday that board chair Dorothea Wenzel will step down at its annual general meeting in 2027, with the board intending to elect former Novo Nordisk NOVOb.CO CEO Lars Fruergaard Jorgensen as her successor.
Jorgensen will join the board as an observer from November 10.
(Reporting by Abu Sultan in Bengaluru; Editing by Jan Harvey)
Recent news on Novo Nordisk A/S
See all newsIndia's Torrent Pharma's profit slips as R&D costs outweigh domestic demand
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption
GLP-1 boom in China, India, Brazil could create $22 bln market by 2035, J.P. Morgan says
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption
Weight-loss drugs fuel protein boom, but with more consumer scrutiny